WELLS FARGO & COMPANY/MN - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$81,000
-52.9%
4,620
-73.8%
0.00%
Q2 2021$172,000
-16.5%
17,648
-8.4%
0.00%
Q1 2021$206,000
-4.6%
19,273
+31.2%
0.00%
Q4 2020$216,000
+9.1%
14,693
+5.2%
0.00%
Q3 2020$198,000
+395.0%
13,968
+179.4%
0.00%
Q2 2020$40,000
+207.7%
5,000
+51.5%
0.00%
Q1 2020$13,000
+18.2%
3,300
-68.9%
0.00%
Q4 2019$11,000
+450.0%
10,600
+66.9%
0.00%
Q3 2019$2,000
-33.3%
6,350
-19.1%
0.00%
Q2 2019$3,000
-57.1%
7,850
-25.9%
0.00%
Q1 2019$7,000
-63.2%
10,600
-5.4%
0.00%
Q4 2018$19,000
-89.9%
11,200
-65.5%
0.00%
Q3 2018$189,000
-11.7%
32,489
-8.8%
0.00%
Q2 2018$214,000
+13.2%
35,639
+35.7%
0.00%
Q1 2018$189,0000.0%26,260
+0.6%
0.00%
Q4 2017$189,000
+122.4%
26,100
+57.7%
0.00%
Q3 2017$85,000
+23.2%
16,550
+6.4%
0.00%
Q2 2017$69,000
-36.7%
15,550
-12.1%
0.00%
Q1 2017$109,000
+45.3%
17,700
+34.1%
0.00%
Q4 2016$75,000
-57.1%
13,200
+11.9%
0.00%
Q3 2016$175,000
+1844.4%
11,800
+1080.0%
0.00%
Q2 2016$9,0000.0%1,0000.0%0.00%
Q1 2016$9,000
-30.8%
1,0000.0%0.00%
Q4 2015$13,0000.0%1,0000.0%0.00%
Q3 2015$13,0001,0000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders